About Blood Processing Devices and Consumables
Globally, blood processing devices and consumables are getting attention from various healthcare institutions and other medical facilities where blood storage and transfusion have been part of improved patient treatment. Cord blood processing is gaining critical importance for stem cell research as well as blood disease therapy and the limited availability of cord blood is an urgent market need. Electrically aided centrifugal technique and novel filter using gentle gravity-dependent flow techniques are gaining prominence for cord blood processing.
Technavio’s analysts forecast the global blood processing devices and consumables market to grow at a CAGR of 8.52% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global blood processing devices and consumables market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of blood processing devices and consumables.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Blood Processing Devices and Consumables Market 2016-2020
Technavio recognizes the following companies as the key players in the global blood processing devices and consumables market: Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Beckman Coulter, Fenwal, Fresenius Kabi, Grifols International, Haemonetics, Immucor, Macopharma, Roche Holdings, Stago, and Terumo.
Commenting on the report, an analyst from Technavio’s team said: “Increasing blood transfusion surgical procedures will be a key trend for market growth. The number of surgeries are growing rapidly across the world. Changes in lifestyle, immunodeficiency diseases, and other factors are leading to direct and indirect healthcare admission for treatment. This is increasing the demand for blood transfusion devices. This scenario is observed across all developed, developing, and few underdeveloped countries. The proportion of patients using blood transfusion devices may vary, but the impact has been clear on this industry, resulting in high demand for these devices.”
According to the report, one of the key drivers for market growth will be rising automation of devices in blood processing. Traditionally utilized manual methods pose a lot of challenges in blood processing. Difficulty in maintaining data regarding product and process control, recording and tracking, regulatory requirements, and staffing issues are some of the challenges. The automated devices include whole blood collection devices and automated cell processors. The demand for automated devices has been increasing as their use saves time and offers enhanced operational efficiency.
Further, the report states that lack of systematic data tracking methods will be a major challenge for the market. The chances of incomplete data collection are high in case of manual collection systems. As the data entry is carried out by more than one person, it leads to confusion and incomplete data. This can be avoided if only one person is handling the data collection process. The manual entry of details of the blood collected from a donor and the labeling of sample packs can lead to confusion while using these packs. It will be difficult to communicate cross functionally in case if any issue arises because of the incomplete understanding of collected data.
Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Fenwal, Fresenius Kabi, Grifols International, Haemonetics, Immucor, Macopharma, Roche Holdings, Stago, Terumo.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook